ASO Visual Abstract: Plasma Ceramide C24:0/C16:0 Ratio is Associated with Improved Survival in Patients with Pancreatic Ductal Adenocarcinoma

Ann Surg Oncol. 2025 Jan;32(1):537-538. doi: 10.1245/s10434-024-16375-6.

Joshua D Mitchell^{1

2}, Usman Panni³, Nicole Fergestrom⁴, Adetunji T Toriola^{2

5}, Timothy M Nywening³, S Peter Goedegebuure^{2

3}, Xuntian Jiang¹, Jacqueline L Mudd³, Yin Cao^{2

5}, Joseph Ippolito², Ryan C Fields^{2

3}, William G Hawkins^#⁶, Linda R Peterson^#⁷

¹ Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
² Alvin J Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.
³ Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
⁴ Center for Advancing Population Science, Medical College of Wisconsin, Milwaukee, WI, USA.
⁵ Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
⁶ Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.
⁷ Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA. [email protected].

^# Contributed equally.

No abstract available